エフリン-B2は,VEGF誘発の血管新生とリンパ血管新生を制御する
Yingdi Wang1, Masanori Nakayama, Mara E Pitulescu
1Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK.
Nature
|May 7, 2010
まとめ
エフリンB2は,血管内皮成長因子受容体3 (VEGFR3) のシグナル伝達を調節することにより,血管およびリンパ血管の成長に不可欠です. この発見は,発達と疾患における血管新生とリンパ血管新生に関する理解を深める.
科学分野:
- 分子生物学は分子生物学である.
- 発達生物学 発達生物学とは
- 細胞生物学 細胞生物学
背景:
- 血管新生とリンパ血管新生は,内皮細胞の増殖と発芽を伴う.
- 血管内皮成長因子 (VEGF) などの組織由来信号がこれらのプロセスを引き起こす.
- 血管新生中の内皮細胞のシグナル伝達経路は完全に理解されていません.
研究 の 目的:
- エフリン-B2の血管新生生芽生えと内皮細胞の運動性における役割を調査する.
- エフリン-B2とVEGFシグナル伝達経路の関係を明らかにし,特にVEGFR3.3に焦点を当てた.
主な方法:
- ネズミとゼブラフィッシュのモデルでの遺伝子実験.
- 細胞培養の研究は,受容体内化と下流信号伝達の検査を目的としています.
主要な成果:
- エフリン-B2は,血管新生性エンドテリウムにおける発芽行動と運動性を促進する.
- エフリンB2は,VEGF-Cの受容体であるVEGFR3の内部化に不可欠です.
- エフリン-B2の欠如によるVEGFR3内部化の欠陥は,下流信号伝達経路 (Rac1,Akt,Erk) を損なう.
結論:
- VEGFR3の完全なシグナル伝達は,受容体の内部化に依存しています.
- エフリン-B2は,VEGFR3内部化の主要な調節剤として作用する.
- エフリン-B2は,VEGFR3信号伝達を調節することによって,血管新生およびリンパ血管新生の成長を制御します.
関連する概念動画
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K


